Dr. Reddy's Laboratories Limited
RDY
$13.67
-$0.12-0.87%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.29% | -0.68% | 1.48% | 3.48% | 15.58% |
| Total Depreciation and Amortization | 16.59% | 12.46% | 11.74% | 9.08% | 12.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 193.32% | 157.09% | 71.72% | -44.36% | -124.59% |
| Change in Net Operating Assets | 1.84% | -46.92% | -205.08% | -719.57% | -189.24% |
| Cash from Operations | 19.51% | -0.70% | -33.83% | -53.36% | -33.72% |
| Capital Expenditure | -59.90% | -64.04% | -80.08% | -67.09% | -50.59% |
| Sale of Property, Plant, and Equipment | -72.71% | -52.32% | -45.06% | 87.93% | 1,602.89% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.69% | 187.60% | 160.71% | 111.81% | -7.62% |
| Cash from Investing | -6.65% | -41.72% | -24.12% | -19.92% | -15.98% |
| Total Debt Issued | -12.86% | 163.53% | 233.68% | 769.71% | 322.61% |
| Total Debt Repaid | -189.47% | 73.84% | 85.17% | 96.39% | 96.94% |
| Issuance of Common Stock | -50.34% | -76.02% | -78.59% | -81.54% | 79.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.09% | 1.09% | 1.09% | 1.09% | -28.80% |
| Other Financing Activities | 229.76% | 257.68% | 289.00% | 304.72% | -30.38% |
| Cash from Financing | 16.54% | 597.54% | 434.86% | 345.66% | 139.60% |
| Foreign Exchange rate Adjustments | 698.99% | 454.01% | 10.33% | 117.42% | 114.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 281.55% | 430.31% | 308.11% | -151.26% | -320.69% |